Cargando…
Retinoic acid pathway activity in wilms tumors and characterization of biological responses in vitro
BACKGROUND: Wilms tumor (WT) is one of the most common malignancies in childhood. With current therapy protocols up to 90% of patients can be cured, but there is still a need to improve therapy for patients with aggressive WT and to reduce treatment intensity where possible. Prior data suggested a d...
Autores principales: | Wegert, Jenny, Bausenwein, Sabrina, Kneitz, Susanne, Roth, Sabine, Graf, Norbert, Geissinger, Eva, Gessler, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239322/ https://www.ncbi.nlm.nih.gov/pubmed/22067876 http://dx.doi.org/10.1186/1476-4598-10-136 |
Ejemplares similares
-
High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro
por: Wegert, Jenny, et al.
Publicado: (2019) -
TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia
por: Wegert, Jenny, et al.
Publicado: (2017) -
MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates
por: Jiménez Martín, Ovidio, et al.
Publicado: (2021) -
Multiple mechanisms of MYCN dysregulation in Wilms tumour
por: Williams, Richard D., et al.
Publicado: (2015) -
Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
por: Schmitt, Jana, et al.
Publicado: (2011)